Corrigendum to “Beta cell specific cannabinoid 1 receptor deletion counteracts progression to hyperglycemia in non-obese diabetic mice” [Mol Metab 82 (2024 April) 101906]☆
Laboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA
Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA
Inserm UMR1190 - Translational Research of Diabetes, Pôle recherche 3ème Ouest, 1, place de Verdun 59045 Lille Cedex, France
Laboratory of Molecular Biology & Immunology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA
Article notes
Untitled section
Collection date 2024 Apr.
The authors regret that the primary affiliation for the first author, where the actual work was done, was missed in the originally published article, but it was the affiliation at the time and remains the affiliation now. The primary affiliation of the first author, Kanikkai Raja Aseer, is with the Laboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA. The authors request to list both the first author's primary affiliation No. 1 and present affiliation No. 2 in the article. The author names and affiliations should read:
Kanikkai Raja Aseer 1,2, Caio Henrique Mazucanti 1, Jennifer F. O’Connell 1, Isabel González-Mariscal 3, Anjali Verma 2, Qin Yao 1, Christopher Dunn 4, Qing-Rong Liu 1, Josephine M. Egan 1, Máire E. Doyle 1,∗
1 Laboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA
2 Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA
3 Inserm UMR1190 - Translational Research of Diabetes, Pôle recherche 3ème Ouest, 1, place de Verdun 59045 Lille Cedex, France
4 Laboratory of Molecular Biology & Immunology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA
The authors would like to apologise for any inconvenience caused.